Rafe Donahue

3.1k total citations
50 papers, 2.1k citations indexed

About

Rafe Donahue is a scholar working on Genetics, Hematology and Surgery. According to data from OpenAlex, Rafe Donahue has authored 50 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 15 papers in Hematology and 11 papers in Surgery. Recurrent topics in Rafe Donahue's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Treatment of Major Depression (8 papers). Rafe Donahue is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Treatment of Major Depression (8 papers). Rafe Donahue collaborates with scholars based in United States, Canada and France. Rafe Donahue's co-authors include Trisha L. Houser, John A. Ascher, Sharyn R. Batey, Harry A. Croft, Alan Metz, Carolyn Watson, Huma Qureshi, Sten H. Vermund, Asad Ali and Edmund C. Settle and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of the American College of Cardiology.

In The Last Decade

Rafe Donahue

48 papers receiving 2.0k citations

Peers

Rafe Donahue

PMH

PHARM

SURGE

EDM

EPIDE

Alan Brnabic United States

Alexandra Gorelik Australia

Eric C. Sayre Canada

Josephine M. Norquist United States

Sally Hollis United Kingdom

Angelique Zeringue United States

Shelagh M. Szabo United States

Anthony V. Perruccio Canada

John H. Mason United States

Eric Gardiner United Kingdom

Alan Brnabic United States

Rafe Donahue

784 ×1.1

PMH

1.0k ×1.9

PHARM

397 ×1.0

SURGE

111 ×0.3

EDM

144 ×0.5

EPIDE

Citations per year, relative to Rafe Donahue Rafe Donahue (= 1×) peers Alan Brnabic

Countries citing papers authored by Rafe Donahue

Since Specialization

Citations

This map shows the geographic impact of Rafe Donahue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafe Donahue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafe Donahue more than expected).

Fields of papers citing papers by Rafe Donahue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafe Donahue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafe Donahue. The network helps show where Rafe Donahue may publish in the future.

Co-authorship network of co-authors of Rafe Donahue

This figure shows the co-authorship network connecting the top 25 collaborators of Rafe Donahue. A scholar is included among the top collaborators of Rafe Donahue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafe Donahue. Rafe Donahue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Harrison, Claire, Ruben A. Mesa, Moshe Talpaz, et al.. (2023). P1044: REDUCTION IN RED BLOOD CELL TRANSFUSION BURDEN: A NOVEL LONGITUDINAL TIME-DEPENDENT ANALYSIS IN PATIENTS WITH TRANSFUSION-DEPENDENT MYELOFIBROSIS TREATED WITH MOMELOTINIB. HemaSphere. 7(S3). e431076c–e431076c. 1 indexed citations

Gerds, Aaron T., Srđan Verstovšek, Alessandro M. Vannucchi, et al.. (2022). Thrombocytopenic myelofibrosis (MF) patients previously treated with a JAK inhibitor in a phase 3 randomized study of momelotinib (MMB) versus danazol (DAN) [MOMENTUM].. Journal of Clinical Oncology. 40(16_suppl). 7061–7061. 5 indexed citations

Mesa, Ruben A., Claire Harrison, Jeanne Palmer, et al.. (2022). The Impact of Momelotinib on Patient Reported Quality of Life for Symptomatic and Anemic Patients with Myelofibrosis: Results from the Phase 3 Momentum Study. Blood. 140(Supplement 1). 9677–9680.

Krause, Fabian, Alastair Younger, Judith F. Baumhauer, et al.. (2016). Clinical Outcomes of Nonunions of Hindfoot and Ankle Fusions. Journal of Bone and Joint Surgery. 98(23). 2006–2016. 27 indexed citations

DiGiovanni, Christopher W., Sheldon S. Lin, Timothy R. Daniels, et al.. (2016). The Importance of Sufficient Graft Material in Achieving Foot or Ankle Fusion. Journal of Bone and Joint Surgery. 98(15). 1260–1267. 43 indexed citations

Lareau, Craig R., Matthew E. Deren, Amanda Fantry, Rafe Donahue, & Christopher W. DiGiovanni. (2015). Does autogenous bone graft work? A logistic regression analysis of data from 159 papers in the foot and ankle literature. Foot and Ankle Surgery. 21(3). 150–159. 46 indexed citations

Spear, Marcia, Lillian B. Nanney, Sharon Phillips, et al.. (2011). The Impact of Reduction Mammaplasty on Breast Sensation. Annals of Plastic Surgery. 68(2). 142–149. 12 indexed citations

Collier, Bryan R., Oscar D. Guillamondegui, Bryan A. Cotton, et al.. (2007). Feeding the Open Abdomen. Journal of Parenteral and Enteral Nutrition. 31(5). 410–415. 81 indexed citations

Ross, Charles B., Yichen Wu, Rafe Donahue, et al.. (2007). Ischemic Complications of Percutaneous Femoral Artery Catheterization. Annals of Vascular Surgery. 21(6). 704–712. 5 indexed citations

10.

Donahue, Rafe, et al.. (2006). Cost-effective use of breast biopsy techniques in a veterans health care system. The American Journal of Surgery. 192(5). e37–e41. 25 indexed citations

11.

Weihs, Karen L., Trisha L. Houser, Sharyn R. Batey, et al.. (2002). Continuation phase treatment with bupropion SR effectively decreases the risk for relapse of depression. Biological Psychiatry. 51(9). 753–761. 54 indexed citations

12.

Croft, Harry A., Trisha L. Houser, Brenda D. Jamerson, et al.. (2002). Effect on body weight of bupropion sustained-release in patients with major depression treated for 52 weeks. Clinical Therapeutics. 24(4). 662–672. 47 indexed citations

13.

Rush, A. John, Sharyn R. Batey, Rafe Donahue, et al.. (2001). Does pretreatment anxiety predict response to either bupropion SR or sertraline?. Journal of Affective Disorders. 64(1). 81–87. 24 indexed citations

14.

Trivedi, Madhukar H., A. John Rush, Thomas Carmody, et al.. (2001). Do Bupropion SR and Sertraline Differ in Their Effects on Anxiety in Depressed Patients?. The Journal of Clinical Psychiatry. 62(10). 776–781. 56 indexed citations

15.

Weihs, Karen L., Edmund C. Settle, Sharyn R. Batey, et al.. (2000). Bupropion Sustained Release Versus Paroxetine for the Treatment of Depression in the Elderly. The Journal of Clinical Psychiatry. 61(3). 196–202. 110 indexed citations

16.

Segraves, Robert, Richard J. Kavoussi, Arlene R. Hughes, et al.. (2000). Evaluation of Sexual Functioning in Depressed Outpatients: A Double-Blind Comparison of Sustained-Release Bupropion and Sertraline Treatment. Journal of Clinical Psychopharmacology. 20(2). 122–128. 72 indexed citations

17.

Burke, Thomas A., et al.. (2000). A Comparison of Time-and-Motion and Self-Reporting Methods of Work Measurement. JONA The Journal of Nursing Administration. 30(3). 118–125. 141 indexed citations

18.

Donahue, Rafe. (1999). A Note on Information Seldom Reported via the P Value. The American Statistician. 53(4). 303–306. 19 indexed citations

19.

Croft, Harry A., Edmund C. Settle, Trisha L. Houser, et al.. (1999). A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. Clinical Therapeutics. 21(4). 643–658. 188 indexed citations

20.

Donahue, Rafe. (1997). A summary statistic for measuring change from baseline. Journal of Biopharmaceutical Statistics. 7(2). 287–299. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact